Pharmacopsychiatry

Papers
(The median citation count of Pharmacopsychiatry is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
184
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?66
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study24
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study24
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry22
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System21
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation21
Neuronal Correlates of Delusional Symptomatology in Affective and Psychotic Disorders20
Predicting mental health symptoms with NBS-Predict15
CircRNAs in Peripheral Blood: Potential Biomarkers for Alzheimer’s Disease?15
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries15
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety14
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study13
The Mini-TRH Test13
13
12
Amphiphysin und GAD65 IgG Antikörper bei Zwangsstörungen10
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA10
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response9
7
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS7
News on the Role of Antidepressants in and for COVID-19 and Long COVID7
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation7
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey6
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie6
Patient and Physician Exposure to Artificial Intelligence Hype6
6
Impaired nonverbal communication is associated with symptom severity in Depression5
Longitudinal Multimodal Analysis of Structural Brain Changes and Psychopathology Using Data-Driven Fusion Approaches5
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita5
5
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab5
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes5
5
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis5
Overview: Chronic Pain and Cannabis-Based Medicines4
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?4
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use4
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye4
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review4
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials4
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics4
4
Das therapeutische Potential von niedrig dosiertem Δ9-Tetrahydrocannabinol bei der Modulation der Alzheimer-Pathologie im 5xFAD-Mausmodell3
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa3
Investigating the role of CCL11 in shaping microglial age-and long-COVID-related inflammatory activation3
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs3
Brain Fog reconsidered. Objectifying subjective cognitive impairment following COVID-19 infection.3
Metformin is Protective Against the Development of Mood Disorders3
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality3
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges3
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality3
Predicting one-year postoperative cognitive dysfunction after cardiac surgery by combining markers of amyloid-β and tau pathology3
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study2
In major depression early response to antidepressant treatment in week one is associated with FKBP5-gene variants rs1360780 and rs47139162
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie2
2
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression2
2
Impact of Parkinson Medication on Neuropsychiatric and Neurocognitive Symptoms in Patients with Advanced Parkinson Disease Prior to Deep Brain Stimulation1
1
Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring1
1
CYP1A2 Genotyp-abhängige Auswirkung des Rauchens auf die Mirtazapin Serumkonzentration1
Early Treatment-Resistance in First Episode Psychosis1
Einfluss einer traumafokussierten Psychotherapie auf Zwangs- und somatoformen Symptome: Design einer klinischen Längsschnittstudie1
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis1
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme1
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders1
Are Intravenous Subnarcotic Ketamine Infusions as an Adjunct Treatment for Treatment-Resistant Depression Ready to be Recommended in European Guidelines?1
Early phase of a seronegative autoimmune psychosis with increased kappa free light chains1
Activation of Hippocampal Neuronal NADPH Oxidase NOX2 Promotes Depressive-Like Behaviour and Cognition Deficits in Chronic Restraint Stress Mouse Model1
Investigation of Stress-Induced Cortisol Effects on Decision Making After Pharmacological Mineralocorticoid or Glucocorticoid Receptor Blockade1
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA1
Human Derived Dermal Fibroblasts as in Vitro Research Tool to Study Circadian Rhythmicity in Psychiatric Disorders1
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine 1
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality1
Geschlechter im Fokus: Welche Rolle spielt der 5-HT2C-Rezeptor in der lateralen Habenula in einem Mausmodell der schweren Depression?0
Initial Evidence of CES1 Gene Variants Influencing the Pharmacokinetics and Clinical Effects of Methylphenidate0
Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report0
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry0
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major Depression0
A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study0
Der Zusammenhang zwischen belastenden Lebensereignissen, DMN-Konnektivität und MDD- Remission: Eine fMRT-gestützte Analyse0
Effekte eines sechswöchigen hochfrequenten standardisierten Sportprogramms (SIWAS) auf die Herzfrequenzvariabilität bei Patient*innen mit psychiatrischen Erkrankungen0
Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder0
Establishing Core Symptoms of Acute Serotonin Reuptake Inhibitor Withdrawal: Results from an International Survey of Online Peer-Support Communities0
Is Lumateperone Effective in Bipolar Depression? A Systematic Literature Review and Meta-Analysis on Placebo-Controlled Trials0
COVID-19 Prognosis in Association with Antidepressant Use0
Arzneimittelsicherheit in der Psychiatrie Hautexanthem mit Eosinophilie unter Lithium0
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study0
0
0
„AGNP-Preis für Forschung in der Psychopharmakologie“ in Höhe von 5.000 €0
Medical Cannabis in Psychiatry0
0
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multic0
Association of Physical Activity and Bone Mineral Density in Adults with Depressive Symptoms0
0
0
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study0
Neural links of paranoia in a transdiagnostic sample0
0
How to Improve Methodological Issues in Clinical Trials to Confirm that Pentoxifylline is Useful as an Add-on Therapy for Major Depressive Disorder0
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial0
Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review0
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point0
Entgiftung bei Alkoholabhängigen mit Clomethiazol oder Diazepam – Vergleich von Behandlungsvariablen0
0
The BIPCOVID Study: Investigating Shared Genetic Pathways Between COVID-19 Susceptibility and Psychiatric Symptoms in Bipolar Disorder0
Neuroimaging-gestützte Charakterisierung von Schlafstörungen und Depressionen0
Clozapine-Induced Stuttering: Case Report and Literature Review0
Morphological Representation of C1q in the Aging Central Nervous System0
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice0
Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment0
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial0
Pharmacological Treatment of Autism Spectrum Disorder: A Systematic Review of Treatment Guidelines0
Citalopram als potenzielle Therapie und Prophylaxe für Alzheimer: Experimentelle Untersuchungen im 5xFAD-Mausmodell0
Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection0
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease0
Instruments Assessing Medication Literacy in Psychiatric Patients and the Caregivers: A Systematic Review0
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany0
A genome-wide association study of brain function across multiple cognitive domains0
A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection0
Cannabinoids for Behavioral Symptoms in Dementia: An Overview0
Diversion and Abuse of Prescribed Methylphenidate – A Survey of an Outpatient Clinic for Adult Persons with ADHD0
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties0
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum D0
0
Predicting Future Cognitive Decline Using Novel fMRI-Based Biomarkers in Preclinical Alzheimer's Disease0
Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series0
Was heißt hier Remission? Eine Sekundäranalyse der longitudinalen EMC-Studie0
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammati0
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine0
Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review0
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy0
The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response0
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients0
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis0
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?0
Transdiagnostic types of formal thought disorder and their association with gray matter brain structure: a model-based cluster analytic approach0
Stratifizierung des Risikos für die Anwendung von Zwangsmaßnahmen mit Hilfe von künstlicher Intelligenz und elektronischen Gesundheitsdaten0
Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature0
The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms0
Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany0
Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder0
Cognitive Side Effects of Electroconvulsive Therapy: A Case-Control Comparison in Obsessive-Compulsive and Depressive Disorders0
Hirnvolumetrie bei Patienten mit Alkoholabhängigkeit0
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integratio0
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey0
0
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature0
Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedica0
Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments0
Effects of long-term thiethylperazine treatment on Alzheimer's pathology in Tg4-42 mice: Therapeutic Potential vs. Adverse Effects0
Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study0
Covid-19: Contributions from Psychopharmacology0
Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark0
Classic Psychedelic Drugs: Update on Biological Mechanisms0
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, R0
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis0
Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments0
Ensemble Machine Learning Model for Real-Time Valproic Acid Prediction in Epilepsy Treatment0
Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment0
Implications of Online Self-Diagnosis in Psychiatry0
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism0
Correction: Lithium Therapy in Old Age: Recommendations from a Delphi Survey0
„Peter Müller Preis für Forschung im Bereich Schizophrenie“ in Höhe von 5.000€0
Patient Perspectives on Pharmacotherapy of Alcohol Dependence0
0
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels0
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years0
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy0
Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range0
Lithium Therapy in Old Age: Recommendations from a Delphi Survey0
Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression0
Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?0
Interpersonal Needs, Mental Pain, and Hopelessness in Psychiatric Inpatients with Suicidal Ideation0
Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia0
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review0
Untersuchung des Sozialverhaltens in einem Rattenmodell der bipolaren Störung0
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Stu0
0
0
Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis0
0.043636083602905